We are live on ! Find out more
RCAP

Resolute Capital Asset Partners Portfolio holdings

AUM $190M
1-Year Est. Return 160.65%
This Fund
S&P 500
This Quarter Est. Return
+20.33%
1 Year Est. Return
+160.65%
3 Year Est. Return
+636.52%
5 Year Est. Return
10 Year Est. Return
AUM
$207M
AUM Growth
+$15.8M
Cap. Flow
-$3.82M
Cap. Flow %
-1.85%
Top 10 Hldgs %
51.98%
Holding
71
New
27
Increased
5
Reduced
13
Closed
22

Top Buys

Rank Stock Value
1
TPL icon
Texas Pacific Land
TPL
+$13.9M
2
ANDE icon
Andersons Inc
ANDE
+$11.7M
3
AMZN icon
Amazon
AMZN
+$7.13M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$6.13M
5
CR icon
Crane Co
CR
+$5.57M

Top Sells

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$15.9M
2
BABA icon
Alibaba
BABA
+$7.15M
3
VVV icon
Valvoline
VVV
+$6.28M
4
FTAI icon
FTAI Aviation
FTAI
+$5.84M
5
TSM icon
TSMC
TSM
+$5.59M

Sector Composition

Rank Sector Weight
1 Healthcare 36.85%
2 Industrials 13.36%
3 Consumer Staples 11.45%
4 Consumer Discretionary 9.74%
5 Energy 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.4B
$18.9M 9.13%
88,627
-77,045
-47% -$15.9M
AMZN icon
2
Amazon
AMZN
$2.47T
$16.4M 7.94%
71,158
+31,158
+78% +$7.13M
ANDE icon
3
Andersons Inc
ANDE
$2.56B
$13.8M 6.68%
260,000
+240,000
+1,200% +$11.7M
TPL icon
4
Texas Pacific Land
TPL
$27B
$13.1M 6.31%
+45,500
New +$13.9M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$3.99T
$9.41M 4.55%
30,000
ABVX
6
Abivax
ABVX
$10.7B
$8.77M 4.24%
65,000
+25,000
+63% +$2.73M
CDTX
7
DELISTED
Cidara Therapeutics
CDTX
$8.24M 3.98%
37,315
-20,000
-35% -$3.23M
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$16.3B
$6.8M 3.29%
+40,000
New +$6.13M
MDGL icon
9
Madrigal Pharmaceuticals
MDGL
$12.7B
$6.36M 3.07%
10,918
-4,082
-27% -$2.08M
TMO icon
10
Thermo Fisher Scientific
TMO
$217B
$5.79M 2.8%
10,000
-5,000
-33% -$2.83M
CR icon
11
Crane Co
CR
$13B
$5.53M 2.67%
+30,000
New +$5.57M
SCHW
12
Charles Schwab
SCHW
$183B
$5.5M 2.65%
55,000
-25,000
-31% -$2.37M
SNPS icon
13
Synopsys
SNPS
$74B
$4.7M 2.27%
10,000
-5,000
-33% -$2.22M
DHR icon
14
Danaher
DHR
$147B
$4.58M 2.21%
+20,000
New +$4.4M
GKOS icon
15
Glaukos
GKOS
$8.78B
$4.57M 2.21%
+40,500
New +$3.87M
BG icon
16
Bunge Global
BG
$23.1B
$4.45M 2.15%
+50,000
New +$4.61M
APG icon
17
APi Group
APG
$16.9B
$4.4M 2.13%
115,000
+15,000
+15% +$555K
AIR icon
18
AAR Corp
AIR
$5.4B
$4.14M 2%
+50,000
New +$4.14M
CYTK icon
19
Cytokinetics
CYTK
$10.9B
$4.13M 2%
65,000
+5,000
+8% +$311K
NRG icon
20
NRG Energy
NRG
$27.6B
$3.98M 1.92%
25,000
-10,000
-29% -$1.65M
AMRZ
21
Amrize Ltd
AMRZ
$28B
$3.79M 1.83%
+70,000
New +$3.57M
AZO icon
22
AutoZone
AZO
$51.4B
$3.73M 1.8%
+1,100
New +$4.16M
KEX icon
23
Kirby Corp
KEX
$7.73B
$3.31M 1.6%
+30,000
New +$3.05M
VST icon
24
Vistra
VST
$50.7B
$3.23M 1.56%
+20,000
New +$3.64M
CRS icon
25
Carpenter Technology
CRS
$28.2B
$3.15M 1.52%
10,000

Similar funds

Resolute Capital Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Resolute Capital Asset Partners held 71 positions worth $207M, up 8.3% from $191M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Resolute Capital Asset Partners's Q4 2025 filing shows 27 new, 5 increased, 13 reduced and 22 closed positions. Its largest new stake was Texas Pacific Land: 45,500 shares worth $13.1M. The largest sale was Ascendis Pharma A/S, an estimated $15.9M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 43% a quarter earlier, followed by Industrials and Consumer Staples.

  • Resolute Capital Asset Partners's largest Q4 2025 buy was Texas Pacific Land: 45,500 shares worth $13.1M.
  • Resolute Capital Asset Partners added most to Andersons Inc in Q4 2025, an estimated $11.7M increase.
  • Resolute Capital Asset Partners's biggest Q4 2025 reduction was Ascendis Pharma A/S, cutting an estimated $15.9M.
  • Resolute Capital Asset Partners fully exited Alibaba in Q4 2025, selling an estimated $7.15M.
  • Resolute Capital Asset Partners's ten largest holdings make up 52% of its $207M portfolio in Q4 2025.
  • Resolute Capital Asset Partners opened 27 new positions and closed 22 in Q4 2025.
  • Resolute Capital Asset Partners's portfolio value rose 8.3% quarter-over-quarter to $207M.

Based on Resolute Capital Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.